BERBERIAN LANCE
SEC CIK 1102900 · EDGAR
BoughtSold
Most active insiders at PRVA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Morris Matthew Shawn | Dir | — | $11.88M |
| 2 | Mehrotra Parth | CEO, Dir | — | $6.43M |
| 3 | Mountcastle David | EVP, CFO | — | $3.72M |
| 4 | Fargis Edward C | EVP, GC | — | $214.8K |
| 5 | Ernest Opella Finley | Dir | — | — |
| 6 | Ryu Jaewon | Dir | — | — |
| 7 | Kimmet Pamela O | Dir | — | — |
| 8 | McCarthy Thomas A | Dir | — | — |
| 9 | KING DAVID P | Dir | — | — |
| 10 | SOISTMAN FRANCIS S JR | Dir | — | — |
| 12 | BERBERIAN LANCE | Dir | — | — |
Transactions 33
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-22 08:26 | 2026-05-20 | PRVA | Privia Health Group, Inc. | BERBERIAN LANCE | Dir | A - Grant | $0.00 | +8,463 | 16.1K | +110% | $0 | |
| 2025-07-17 | 2025-07-15 | PRVA | Privia Health Group, Inc. | BERBERIAN LANCE | Dir | A - Grant | $0.00 | +7,668 | 7,668 | New | $0 | |
| 2025-03-31 | 2025-03-27 | LH | Labcorp | BERBERIAN LANCE | EVP, Special Advisor, Strategy | F - Tax | $231.67 | -1,353 | 18.7K | -7% | -$313.4K | |
| 2025-03-31 | 2025-03-27 | LH | Labcorp | BERBERIAN LANCE | EVP, Special Advisor, Strategy | A - Grant | $0.00 | +3,325 | 20.0K | +20% | $0 | |
| D | 2025-02-13 | 2025-02-11 | LH | Labcorp | BERBERIAN LANCE | EVP, Special Advisor, Strategy | M - OptEx | — | +323 | 16.8K | +2% | — |
| D | 2025-02-13 | 2025-02-11 | LH | Labcorp | BERBERIAN LANCE | EVP, Special Advisor, Strategy | F - Tax | $245.14 | -86 | 16.7K | -0.5% | -$21.1K |
| DM | 2025-02-10 | 2025-02-06+ | LH | Labcorp | BERBERIAN LANCE | EVP, Special Advisor, Strategy | M - OptEx | — | +710 | 16.3K | +5% | — |
| DM | 2025-02-10 | 2025-02-06+ | LH | Labcorp | BERBERIAN LANCE | EVP, Special Advisor, Strategy | F - Tax | $247.01 | -188 | 16.4K | -1% | -$46.4K |
| M | 2024-08-07 | 2024-08-05 | LH | Labcorp | BERBERIAN LANCE | EVP, CIO, CTO | S - Sale | $229.11 | -12.1K | 15.9K | -43% | -$2.77M |
| D | 2024-03-29 | 2024-03-27 | LH | Labcorp | BERBERIAN LANCE | EVP, CIO, CTO | M - OptEx | — | +7,697 | 31.3K | +33% | — |
| D | 2024-03-29 | 2024-03-27 | LH | Labcorp | BERBERIAN LANCE | EVP, CIO, CTO | F - Tax | $216.57 | -3,299 | 28.0K | -11% | -$714.5K |
| D | 2024-02-13 | 2024-02-12 | LH | Labcorp | BERBERIAN LANCE | EVP, CIO, CTO | F - Tax | $227.45 | -87 | 23.6K | -0.4% | -$19.8K |
| D | 2024-02-13 | 2024-02-11 | LH | Labcorp | BERBERIAN LANCE | EVP, CIO, CTO | M - OptEx | — | +324 | 23.7K | +1% | — |
| D | 2024-02-08 | 2024-02-07 | LH | Labcorp | BERBERIAN LANCE | EVP, CIO, CTO | F - Tax | $223.71 | -94 | 23.4K | -0.4% | -$21.0K |
| D | 2024-02-08 | 2024-02-07 | LH | Labcorp | BERBERIAN LANCE | EVP, CIO, CTO | M - OptEx | — | +353 | 23.5K | +2% | — |
| D | 2024-02-06 | 2024-02-02 | LH | Labcorp | BERBERIAN LANCE | EVP, CIO, CTO | M - OptEx | — | +331 | 23.2K | +1% | — |
| D | 2024-02-06 | 2024-02-02 | LH | Labcorp | BERBERIAN LANCE | EVP, CIO, CTO | F - Tax | $221.54 | -89 | 23.1K | -0.4% | -$19.7K |
| 2023-04-03 | 2023-03-30 | LH | Labcorp | BERBERIAN LANCE | EVP, CIO, CTO | F - Tax | $224.70 | -1,799 | 22.9K | -7% | -$404.2K | |
| 2023-04-03 | 2023-03-30 | LH | Labcorp | BERBERIAN LANCE | EVP, CIO, CTO | A - Grant | $0.00 | +4,509 | 24.7K | +22% | $0 | |
| D | 2023-02-14 | 2023-02-11 | LH | Labcorp | BERBERIAN LANCE | EVP, CIO, CTO | M - OptEx | — | +290 | 20.3K | +1% | — |
| D | 2023-02-14 | 2023-02-13 | LH | Labcorp | BERBERIAN LANCE | EVP, CIO, CTO | F - Tax | $248.13 | -85 | 20.2K | -0.4% | -$21.1K |
| D | 2023-02-07 | 2023-02-06 | LH | Labcorp | BERBERIAN LANCE | EVP, CIO, CTO | F - Tax | $244.50 | -108 | 20.0K | -0.5% | -$26.4K |
| D | 2023-02-07 | 2023-02-04 | LH | Labcorp | BERBERIAN LANCE | EVP, CIO, CTO | M - OptEx | — | +374 | 20.1K | +2% | — |
| D | 2023-02-06 | 2023-02-02 | LH | Labcorp | BERBERIAN LANCE | EVP, CIO, CTO | F - Tax | $254.99 | -102 | 19.7K | -0.5% | -$26.0K |
| D | 2023-02-06 | 2023-02-02 | LH | Labcorp | BERBERIAN LANCE | EVP, CIO, CTO | M - OptEx | — | +297 | 19.8K | +2% | — |
| 2022-03-29 | 2022-03-28 | LH | Labcorp | BERBERIAN LANCE | EVP, CIO, CTO | F - Tax | $276.42 | -2,360 | 19.5K | -11% | -$652.4K | |
| 2022-03-29 | 2022-03-27 | LH | Labcorp | BERBERIAN LANCE | EVP, CIO, CTO | A - Grant | $0.00 | +5,310 | 21.9K | +32% | $0 | |
| DM | 2022-02-15 | 2022-02-14 | LH | Labcorp | BERBERIAN LANCE | EVP, CIO, CTO | F - Tax | $272.68 | -799 | 16.7K | -5% | -$217.9K |
| DM | 2022-02-15 | 2022-02-12 | LH | Labcorp | BERBERIAN LANCE | EVP, CIO, CTO | M - OptEx | — | +2,708 | 17.4K | +18% | — |
| D | 2022-02-08 | 2022-02-04 | LH | Labcorp | BERBERIAN LANCE | EVP, CIO, CTO | F - Tax | $277.48 | -109 | 14.6K | -0.7% | -$30.2K |
| D | 2022-02-08 | 2022-02-04 | LH | Labcorp | BERBERIAN LANCE | EVP, CIO, CTO | M - OptEx | — | +373 | 14.8K | +3% | — |
| D | 2022-02-04 | 2022-02-02 | LH | Labcorp | BERBERIAN LANCE | EVP, CIO, CTO | F - Tax | $273.18 | -103 | 14.4K | -0.7% | -$28.1K |
| D | 2022-02-04 | 2022-02-02 | LH | Labcorp | BERBERIAN LANCE | EVP, CIO, CTO | M - OptEx | — | +296 | 14.5K | +2% | — |
Purchase Sale Sale after option exercise All abbreviations